GSK seeks European approval for eltrombopag to treat severe aplastic anaemia

British drug-maker GlaxoSmithKline (GSK) has submitted a marketing authorisation application to the European Medicines Agency (EMA) seeking an additional indication for eltrombopag (Revolade).
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news